Background: The diagnostic criteria for Cirrhotic Cardiomyopathy (CCM) were recently revised to reflect the contemporary advancements in echocardiographic technology. This study evaluates the prevalence of CCM, according to the new criteria, and its impact on post-transplant cardiovascular disease.Methods: This is a single center retrospective matched cohort study of liver transplant (LT) recipients between 01/2008 and 11/2017.